Bioethics Related Topics 
STAT
FEBRUARY 7, 2025
The National Bioethics Advisory Commission estimates there are more than 280 million samples in the United States, with more than 20 million added annually. Those of us in research routinely store patient samples — blood, fluids, tissue, scrapings, and other biological materials — collected during clinical care.
STAT
AUGUST 11, 2024
As executive director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, my work includes legal, ethical, and policy analysis surrounding psychedelic medicine. But if lessons from reproductive health are any signal, I believe there is a future for psychedelics in health care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
NOVEMBER 6, 2023
Bioethics guru Arthur Caplan of NYU gives his outspoken and frank opinion on the industry’s minefield of ethical challenges.
STAT
NOVEMBER 1, 2023
Given workforce shortages, clinician burnout, rising drug costs, and a surging aging population, “it’s not that big a leap to say that more such purchases are going to occur,” said Robert Klitzman, a Columbia psychiatry professor and director of its bioethics masters program.
STAT
SEPTEMBER 16, 2024
Today, we talk about bioethics, catch up on some reports from ESMO, and wonder aloud and in print over a surprising liquid biopsy bet. The need-to-know this morning Ascendis Pharma reported positive results from a Phase 3 study of Transcon CNP in children with achondroplasia, the most common form of dwarfism.
Outsourcing Pharma
JANUARY 12, 2023
The not-for-profit organization published its fair inclusion score to measure and rank pharmaceutical companies on their inclusion of women, older adults, and racial and ethnic minoritized patients.
STAT
MARCH 6, 2023
”It’s imprudent and unwise and not the way forward, even for people who are very ill,” said Dr. Arthur Caplan, a professor of bioethics at the NYU Langone hospital system in New York who chaired a university panel that studied the FDA’s compassionate use program.
Expert insights. Personalized for you.
204 
Let's personalize your content